诺华上诉失败,IRA药品谈判再迎重挫

新浪财经
Sep 15, 2025

(来源:医趋势)据外媒ENDPOINTS报道,美国第三巡回上诉法院周四驳回了诺华针对《通胀削减法案》(IRA)药品价格谈判机制的挑战。这一裁定紧随上周对强生和百时美施贵宝类似诉讼的驳回。法院在判决书中指出,药企参与医保药品价格谈判是自愿的,因此并未侵犯诺华的言论自由或财产权利。判决同时援引了此前强生和百时美施贵宝案件的裁定逻辑。法院在文件中写道,《通胀削减法案》“为选择不参与该项目的公司提供了退出...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10